2023 Nurse's Drug Handbook
暫譯: 2023 護理藥物手冊

2023 Nurse's Drug Handbook is the most up-to-date, practical, and easy-to-use nursing drug reference. Updated annually, it provides accurate and timely facts on hundreds of drugs from A-Z. Written in a straightforward style with approachable terminology, it offers concise and consistently formatted drug entries organized alphabetically. The 2023 Nurse's Drug Handbook includes: - Index of all generic, trade, and alternate drug names - Chemical and therapeutic classes, FDA pregnancy risk category, and controlled substance schedule - Indications and dosages, as well as route, onset, peak, and duration information - Incompatibilities and contraindications - Interactions with drugs, food, and activities - Adverse reactions - Nursing considerations, including key teaching points for patients - Mechanism-of-action illustrations - Warnings and precautions - Updated appendices, including Uncommon Drugs - Bolded life-threatening Adverse Drug Reactions (ADRs) New drugs added to the 2023 Nurse's Drug Handbook include: Aducanumab-avwa, Atogepant, Baricitini, Cabotegravi, Dasiglucagon, Difelikefalin, Evinacumab-dgnb, Finerenone, Ibrexafungerp, Inclisiran, Molnupiravir, Nirmatrelvir, Ponesimod, Tezepelumab-ekko, Tralokinumab-ldrm, Vericiguat.